The History of Kratom: From Southeast Asia to the West

Kratom history stretches far beyond the American retail shelf — from 19th-century colonial botany through decades of prohibition, a famous 2016 public backlash, and into today’s era of state-by-state regulation. Understanding that arc explains why the legal map looks the way it does — and why every serious vendor’s compliance posture exists.

Deep roots in Southeast Asia

In its native region, kratom leaf was part of daily laboring life for generations — chewed or brewed as tea by farmers and laborers in the heat of the working day. Western science met the tree in the 19th century: botanist Pieter Korthals described the genus in the 1830s, and colonial-era ethnobotanists documented traditional use through the early 1900s. The tree’s cultural role in Indonesia, Thailand and Malaysia long predates any Western market — a history summarized with the supply chain it grew from in where does kratom come from.

The prohibition era begins: Thailand 1943

Thailand banned the kratom tree in 1943 — an act rooted in opium-tax politics as much as public health — and Malaysia’s 1952 Poisons Act followed, criminalizing a plant that grew natively in both countries. That regime defined kratom law in its home region for seventy years, until Thailand legalized kratom in 2018, licensing cultivation and eventually export — one of the modern market’s pivotal turns, covered in kratom laws worldwide.

The internet era and the 2016 backlash

Kratom entered US commerce in the 2000s through online vendors and head shops, growing quietly until two events collided: the FDA’s increasingly hard regulatory line — import alerts, adverse-event warnings, and a 2018 recommendation to schedule kratom — and the DEA’s 2016 attempt to emergency-schedule it, withdrawn after an extraordinary public comment campaign by consumers and members of Congress. The episode established kratom as a permanent federal policy question rather than a quiet niche. The regulatory machinery it left behind is explained in the FDA and kratom.

The safety wake-up call: 2018

The 2018 multistate salmonella outbreak linked to kratom — roughly 200 reported cases — forced the industry’s quality reckoning: batch microbial testing, GMP manufacturing and published COAs moved from optional to expected. That story, and the standards it produced, is told in salmonella and kratom safety and why GMP matters.

The KCPA era: 2019–2026

Post-2018, the industry’s center of gravity shifted to state legislation. The Kratom Consumer Protection Act model — 21+ sales, labeling, testing, adulterant bans — spread state by state, while a counter-wave of full bans advanced in 2025–2026: Louisiana, Connecticut, Kansas, Tennessee. The current map and its fault lines: kratom laws by state and the ban-state list, with the regulatory framework itself in what is the KCPA.

Why the history matters to a buyer

• The legal volatility you navigate today is the direct product of this arc — verify before every order.
• The testing standards you should demand are the hard-won lessons of 2018 — see how to read a COA.
• The category’s survival depends on adult-only, claim-free retail — the standard this site operates under. See age verification explained.

Related reading

• Kratom laws by state (2026) — the current map.
• Kratom alkaloids 101 — the chemistry the history regulated.
• 50 kratom FAQs — legality and buying answered.

These statements have not been evaluated by the FDA. Kratom is not intended to diagnose, treat, cure or prevent any disease. Historical information is educational; not legal advice. Adults 21+ only.